Metabolic Changes in the Activated Human Visual Cortex During Mild Hypoxia
1 other identifier
interventional
25
1 country
1
Brief Summary
The primary objective of this research is to measure changes in neurochemical concentrations during stimulation of the primary visual cortex, in both conditions of normoxia (normal oxygen availability) and induced mild hypoxia (reduced oxygen availability).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2015
CompletedFirst Posted
Study publicly available on registry
June 26, 2015
CompletedStudy Start
First participant enrolled
August 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 26, 2016
CompletedResults Posted
Study results publicly available
May 24, 2018
CompletedMarch 19, 2019
March 1, 2019
1.1 years
June 23, 2015
March 21, 2018
March 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Glutamate Concentration During a Visual Stimulus Measured by fMRS at Normoxia
Relative change in glutamate concentration from rest to visual stimulation as measured by fMRS (with water suppression) in the primary visual cortex during conditions of normoxia.
Baseline and Visual Stimulation at 4 minutes
Change in Glutamate Concentration During a Visual Stimulus Measured by Functional MRS at Hypoxia
Relative change in glutamate concentration from rest to visual stimulation as measured by fMRS (with water suppression) in the primary visual cortex during conditions of hypoxia.
Baseline and Visual Stimulation at 4 minutes
Secondary Outcomes (2)
Brain Activity Measured by Blood Oxygenation Level Dependent (BOLD) Signal at Normoxia
Baseline and Visual Stimulation at 30 seconds
Brain Activity Measured by Blood Oxygenation Level Dependent (BOLD) Signal at Hypoxia
Baseline and Visual Stimulation at 30 seconds
Study Arms (1)
Mild Hypoxia
EXPERIMENTALSubjects are exposed to an intervention that controls the composition of breathed air by using a gas blender (RespirAct). Subjects undergo MRI and MRS while breathing air with both normal oxygen concentration (normoxia) and reduced oxygen concentration (mild hypoxia).
Interventions
During normoxia, the computer-controlled gas blender provides a gas mixture that generates pressures of expired O2 and CO2 similar to the resting values measured for each subject (32-35mmHg and 100-110 mmHg, respectively). During mild hypoxia, we will target the same expired CO2 of normoxia and a 60 mmHg reduction of expired O2 from the resting value (to a minimum limit of 50 mmHg), which is expected to reduce arterial oxygen saturation to 82-85%. In mild hypoxia, the fraction of inspired oxygen is reduced from \~21% (room air) to \~12% (equivalent to an altitude of 4000 meters). During both conditions of normoxia and mild hypoxia, the brain activity of subjects is monitored with functional magnetic resonance spectroscopy (fMRS) while they are presented with visual stimuli.
Eligibility Criteria
You may not qualify if:
- Subjects with any type of bio-implant activated by mechanical, electronic, or magnetic means (e.g. cochlear implants, pacemakers, neurostimulators, biostimulators, electronic infusion pumps, etc.).
- Subjects with any type of ferromagnetic bio-implant that could potentially be displaced or damaged, such as aneurysm clips, metallic skull plates, etc.
- Females.
- Subjects that exhibit noticeable anxiety and/or claustrophobia.
- Subjects who cannot adhere to the experimental protocol for any reason.
- Subjects who have cardiac or known circulatory impairment, and/or the inability to perspire (poor thermoregulatory function).
- Subjects who have known conditions which can lead to emergency medical care.
- Been diagnosed by a physician as having a psychiatric disorder, substance abuse, neurological, cardiovascular.
- Been diagnosed by a physician as having respiratory diseases.
- Had a brain tumor or stroke.
- Started taking chemotherapy or immunomodulatory agents, or had any radiation treatment that could affect the brain.
- Had two or more seizures, or been given a diagnosis of epilepsy.
- Gotten a non-removable piercing or permanent eyeliner.
- Had a head injury that caused you to lose consciousness for more than 30 minutes or have amnesia for more than 24 hours.
- Anyone with a history of sleep apnea or head trauma that may have caused Traumatic Brain Injury (TBI).
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Magnetic Resoance Research, University of Minnesota
Minneapolis, Minnesota, 55455, United States
Related Publications (2)
Ho YC, Vidyasagar R, Shen Y, Balanos GM, Golay X, Kauppinen RA. The BOLD response and vascular reactivity during visual stimulation in the presence of hypoxic hypoxia. Neuroimage. 2008 Jun;41(2):179-88. doi: 10.1016/j.neuroimage.2008.02.048. Epub 2008 Mar 6.
PMID: 18396415BACKGROUNDTuunanen PI, Murray IJ, Parry NR, Kauppinen RA. Heterogeneous oxygen extraction in the visual cortex during activation in mild hypoxic hypoxia revealed by quantitative functional magnetic resonance imaging. J Cereb Blood Flow Metab. 2006 Feb;26(2):263-73. doi: 10.1038/sj.jcbfm.9600186.
PMID: 16079793BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Silvia Mangia, PhD
- Organization
- University of Minnesota
Study Officials
- PRINCIPAL INVESTIGATOR
Silvia Mangia, PhD
University of Minnesota
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2015
First Posted
June 26, 2015
Study Start
August 13, 2015
Primary Completion
September 26, 2016
Study Completion
September 26, 2016
Last Updated
March 19, 2019
Results First Posted
May 24, 2018
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share